Blog
Updates, clinical insights, and thought leadership on mRNA gene expression, metabolic therapy monitoring, and longevity pathways from the Biomeme Labs team.
How GLP-1 Medicines Calm Systemic Inflammation Independent of Weight Loss
GLP-1 receptor agonists dramatically lower systemic inflammation. While much of this reduction tracks fat loss, clinical trials reveal an earlier, weight-independent calming effect. Here is the science behind the gut-brain-immune axis—and what it means when the scale pauses.
Why hs-CRP Doesn't Tell the Whole Story: Measuring the Full Inflammatory Arc
High-sensitivity C-reactive protein (hs-CRP) is medicine's gold-standard inflammation marker. But as a delayed liver protein, it captures only an echo of the alarm phase. Here is why measuring the entire inflammatory arc—including resolution—changes how we understand systemic health.
Why Transcriptomics? The Missing Cellular Layer in GLP-1 Care
For decades, medicine monitored health through static blood chemistry and late-stage symptoms. Here is why real-time gene expression is transforming modern therapy from guesswork into precision.